|
Did You Know? |
|
In the U.S. the number of new drugs under development continues to shrink. During the past 3 years FDA approved 68 new drugs: 17 approvals in 2010, 25 in 2009 and 26 in 2008.
In 2008, the top 5 generic drugs sold in the US are
Hydrocodone/APAP ($1.78B),
Simvastatin ($1.45B),
Azithromycin ($1.3B),
Omeprazole ($1.15B), and
Metoprolol Succinate ($1.12B).
The rest...
Drug patent expirations (2008 & 2009):
Acular (used for treat Eye pain),
Arimidex (Breast cancer),
Avandia (Diabetes),
Avelox (Antibiotic),
Cellcept (Organ rejection),
Flomax (BPH),
Glyset (Diabetes),
Imitrex (Migraine),
Keppra (Epilepsy),
Prevacid (Heartburn),
Valtrex (Herpes),
Xenical (Obesity),
Advair (Asthma),
Camptosar (Colon and rectum cancers),
Casodex (Prostate cancer),
Depakote (Epilepsy),
Effexor XR (Depression),
Fosamax (Osteoporosis),
Lamictal (Epilepsy),
Prograf (Organ rejection),
Risperdal (Schizophrenia),
Serevent (Asthma),
Sonata (Insomnia),
Topamax (Migraine),
Trusopt (Glaucoma), and
Zerit (HIV).
In 2008, the top 5 branded drugs sold in the US are
Lipitor ($5.88B),
Nexium ($4.80B),
Plavix ($3.80B),
Advair Diskus ($3.57B), and
Prevacid ($3.3B).
The rest...
In 2007, the top 5 generic drugs used in hospitals in the US are
Lovenox ($1.44B),
Aranesp ($1.2B),
Procrit ($1.2B),
Revlimid ($1.15B), and
Neulasta ($978M).
The rest...
|
| |
